QUINOLINE AND ISOQUINOLINE DERIVATIVES FOR USE AS JAK MODULATORS
申请人:Faraoni Raffaella
公开号:US20130296363A1
公开(公告)日:2013-11-07
Provided herein are compounds for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.